Financials data is unavailable for this security.
View more
Year on year China NT Pharma Group Co Ltd had net income fall 116.23% from a loss of 66.41m to a larger loss of 143.59m despite a -- increase in revenues from 0.00 to 7.37m.
| Gross margin | 18.23% |
|---|---|
| Net profit margin | -89.57% |
| Operating margin | -19.35% |
| Return on assets | -4.02% |
|---|---|
| Return on equity | -- |
| Return on investment | -- |
More ▼
Cash flow in CNYView more
In 2023, cash reserves at China NT Pharma Group Co Ltd fell by 396.00k. However, the company earned 50.48m from its operations for a Cash Flow Margin of 685.26%. In addition the company used 22.14m on investing activities and also paid 28.97m in financing cash flows.
| Cash flow per share | -0.1021 |
|---|---|
| Price/Cash flow per share | -- |
| Book value per share | -1.45 |
|---|---|
| Tangible book value per share | -1.45 |
More ▼
Balance sheet in CNYView more
| Current ratio | 0.0211 |
|---|---|
| Quick ratio | -- |
| Total debt/total equity | -- |
|---|---|
| Total debt/total capital | 35.06 |
More ▼
